Related Experiment Video
Updated: May 30, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Recent advances in the design of drug-loaded polymeric implants for the treatment of solid tumors
Ameena Wadee1, Viness Pillay, Yahya E Choonara
1University of the Witwatersrand, Department of Pharmacy and Pharmacology, Parktown, 2193, Johannesburg, South Africa.
Introduction:
The effective treatment of solid tumors continues to be a great challenge to clinicians, despite the development of novel drugs. In order to improve the clinical efficacy of existing chemotherapeutic agents, researchers have considered the possibility of site-specific solid tumor treatment. The greatest advantage of localized delivery is the significantly fewer side effects experienced by patients. Recently, in situ forming implants have attracted considerable interest. These polymeric systems are injected as solutions into tumor sites and the injected solution forms an implant as a result of local environmental stimuli and hence removes the need for surgical implantation.
Areas Covered:
This review summarizes the attempts that have been made to date in the development of polymeric implants for the treatment of solid tumors. Both in situ forming implants and preformed implants, fabricated using natural and synthetic polymers, are described. In addition, the peri- or intra-tumoral delivery of chemotherapeutic agents based on implants inserted surgically into the affected region is also discussed along with a short coverage of implants having an undesirable initial burst release effect.
Expert Opinion:
Although these implants have been shown to improve the treatment of various solid tumors, the ideal implant that is able to deliver high doses of chemotherapeutics to the tumor site, over prolonged periods with relatively few side effects on normal tissue, is yet to be formulated.
Insights
Polymeric implants offer localized chemotherapy delivery for solid tumors, reducing side effects. While promising, the ideal implant for sustained, high-dose delivery with minimal toxicity is still under development.
Area of Science:
- Biomaterials Science
- Oncology
- Drug Delivery Systems
Background:
- Solid tumor treatment remains challenging despite novel drug development.
- Localized chemotherapy delivery aims to improve efficacy and reduce patient side effects.
- In situ forming implants are gaining interest as a minimally invasive drug delivery method.
Purpose of the Study:
- To review the development of polymeric implants for solid tumor treatment.
- To discuss both in situ forming and preformed implant strategies.
- To cover peri- or intra-tumoral delivery and initial burst release effects.
Main Methods:
- Review of literature on polymeric implants for solid tumors.
- Description of in situ forming and preformed implants (natural and synthetic polymers).
- Discussion of surgical implantation and chemotherapeutic agent delivery.
Main Results:
- Polymeric implants have demonstrated potential in improving solid tumor treatment.
- Both in situ forming and preformed implants are viable strategies.
- Initial burst release can be an undesirable characteristic of some implants.
Conclusions:
- Current implants show promise but have not yet achieved ideal characteristics.
- The ideal implant should provide sustained, high-dose chemotherapy to tumors.
- Minimizing side effects on normal tissues remains a critical goal for future implant development.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Modified-Release Drug Delivery Systems: Site-Targeted
Modified-Release Drug Delivery Systems: Rate-Programmed II
